![\"James](\"https:\/\/thenantwichnews.co.uk\/directory\/wp-content\/uploads\/James-Mackay-everything-genetic-300x212.jpg\")
James Mackay, medical Director at EGL, added: “Although it\u2019s long been understood that genetics plays a part in predisposition to the cancer, this technology gives proven data to demonstrate just how significant a role an individual\u2019s genes might play in the likelihood of them developing cancer.<\/p>\n
“And the earlier we can spot that and take preventative measures, the better.<\/p>\n
“Cancer outcomes are exponentially improved if we can enact lifestyle changes or take clinical treatment sooner.<\/p>\n
“The data from the tests provide three actionable data points for patients, including: absolute risk of developing the specific cancer over the next decade, general population comparison against people the same age, and relative comparison of your risk versus that of the general population.<\/p>\n
“We provide pre- and post-test clinical support to ensure patients are fully aware of the implications of the results and what they can to optimise their health, once they\u2019ve received their data.<\/p>\n
“For example, for breast cancer results above 1.5-fold risk against the general population, we\u2019d advise a screening programme from the age of 35 and for colorectal cancer above 2.0-fold risk, we\u2019d recommend regular bowel screening for those over 35.<\/p>\n
“This technology truly has the potential to turn the old trope of prevention being better than the cure on its head, in identifying predisposition to certain conditions even before prevention.<\/p>\n
“It demonstrates an exciting step in the advancement of life sciences and we really can\u2019t wait to see how the technology impacts individual patients\u2019 outcomes across the UK.”<\/p>\n